-
Basel, June 23, 2022 — Novartis endorses the Kigali Declaration on neglected tropical diseases (NTDs) and announces a five-year financial commitment of USD 250 million to the fight against NTDs and malaria in conjunction with the Kigali Summit on Malaria and NTDs alongside the 26th Commonwealth Heads of Government (CHOGM) meeting. This summit…MalariaInfectious DiseasesFuture of HealthcareAfricaAccess to Healthcare
-
Basel, June 17, 2022 — Sandoz, a global leader in generic and biosimilar medicines, today announced that the European Medicines Agency (EMA) has accepted the application for high concentration formulation 100 mg/mL (HCF) of its biosimilar Hyrimoz® (adalimumab) for regulatory review. The application includes all indications covered by the reference…InnovationFuture of Healthcare
-
Basel, 4. März 2022 – Die Aktionärinnen und Aktionäre von Novartis stimmten heute an der ordentlichen Generalversammlung (GV) des Unternehmens allen Vorschlägen des Verwaltungsrats zu. In Übereinstimmung mit der Schweizer COVID-19-Verordnung 3 wurde die Generalversammlung 2022 ohne physische Anwesenheit der Aktionäre durchgeführt. Dementsprechend…Reimagine MedicineMedical InnovationsFuture of Healthcare
-
Bâle, 4 mars 2022 — Les actionnaires de Novartis ont accepté aujourd’hui les recommandations du Conseil d’administration pour toutes les résolutions proposées lors de l’Assemblée générale ordinaire (AGO) du Groupe. Conformément à l’ordonnance 3 COVID-19 du Conseil fédéral, l’AGO 2022 s’est tenue sans que les actionnaires soient physiquement…Reimagine MedicineMedical InnovationsFuture of Healthcare
-
Basel, March 4, 2022 — Novartis shareholders today agreed to the Board of Directors’ recommendations for all proposed resolutions at the Group’s Annual General Meeting (AGM). In accordance with the Swiss COVID-19 Ordinance 3, the 2022 AGM was held without shareholders being physically present. Accordingly, shareholders exercised their shareholder…Reimagine MedicineMedical InnovationsFuture of Healthcare
-
Bâle, le 2 mars 2021 — Les actionnaires de Novartis ont accepté ce jour les recommandations du Conseil d’administration pour toutes les résolutions proposées lors de l’Assemblée générale (AG) annuelle du groupe. Conformément à l’Ordonnance 3 suisse sur les mesures destinées à lutter contre le COVID-19, l’AG 2021 s’est tenue sans la présence…Reimagine MedicineMedical InnovationsFuture of Healthcare
-
Basel, March 2, 2021 — Novartis shareholders today agreed to the Board of Directors’ recommendations for all proposed resolutions at the Group’s Annual General Meeting (AGM). In accordance with the Swiss COVID-19 Ordinance 3, the 2021 AGM was held without shareholders being physically present. Accordingly, shareholders exercised their shareholder…Reimagine MedicineMedical InnovationsFuture of Healthcare
-
Basel, December 22, 2021 — Novartis announced today that it entered into a definitive agreement to acquire all of the outstanding share capital of the UK-based ocular gene therapy company Gyroscope Therapeutics.OphthalmologyFuture of HealthcareEye CareCell and Gene Therapy
-
Basel, December 2, 2021 — Novartis today holds an investor event to provide a comprehensive overview of the company’s progress in advancing its industry-leading R&D engine.InnovationFuture of HealthcareDrug Development
-
Novartis works with visual artist Noma Bar and international patient group MDS Alliance to send a message of hope to people living with myelodysplastic syndromes.
CancerDisease AwarenessFuture of HealthcareOncologyPatient Education -
Basel, June 23, 2021 — Novartis and Hewlett Packard Enterprise (HPE) today announced a collaboration that aims to accelerate the use of data and digital technologies within Novartis efforts to reimagine global health and improve access to healthcare and medicines.Novartis AccessGlobal Health PartnershipsFuture of HealthcareAccess to Healthcare
-
Basel, July 20, 2021 — Novartis and the Novartis US Foundation today announced a planned 10-year collaboration with Coursera, the National Medical Association, Thurgood Marshall College Fund, Morehouse School of Medicine and 26 additional Historically Black Colleges, Universities and Medical Schools (HBCUs) to co-create programs that address the…Social CommitmentGlobal Health PartnershipsFuture of HealthcareEthical Business
-
Novartis works with visual artist Noma Bar and international patient group MDS Alliance to send a message of hope to people living with myelodysplastic syndromes.